M.V.I. PAEDIATRIC 1.2 MG
VITAMIN B1 (THIAMINE HYDROCHLORIDE) : 1.2 MG VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) : 1.4 MG VITAMIN K1 : .2 MG VITAMIN B12 : 1 MCG VITAMIN A : 2300 UNIT ASCORBIC ACID : 80 MG D-PANTOTHENIC ACID : 5 MG BIOTIN : 20 MCG FOLIC ACID : .14 MG PYRIDOXINE HYDROCHLORIDE : 1 MG VITAMIN E : 7 UNIT NICOTINAMIDE : 17 MG VITAMIN D : 400 UNIT · DIN 01927833 · AVENTIS PHARMA INC
Health Canada status: CANCELLED POST MARKET
What is M.V.I. PAEDIATRIC?
M.V.I. PAEDIATRIC 1.2 MG contains VITAMIN B1 (THIAMINE HYDROCHLORIDE) : 1.2 MG VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) : 1.4 MG VITAMIN K1 : .2 MG VITAMIN B12 : 1 MCG VITAMIN A : 2300 UNIT ASCORBIC ACID : 80 MG D-PANTOTHENIC ACID : 5 MG BIOTIN : 20 MCG FOLIC ACID : .14 MG PYRIDOXINE HYDROCHLORIDE : 1 MG VITAMIN E : 7 UNIT NICOTINAMIDE : 17 MG VITAMIN D : 400 UNIT. It is listed in the Health Canada Drug Product Database under DIN 01927833, held by AVENTIS PHARMA INC, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 29-Jul-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01927833 |
|---|---|
| Brand name | M.V.I. PAEDIATRIC |
| Generic / active ingredient | VITAMIN B1 (THIAMINE HYDROCHLORIDE) : 1.2 MG VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) : 1.4 MG VITAMIN K1 : .2 MG VITAMIN B12 : 1 MCG VITAMIN A : 2300 UNIT ASCORBIC ACID : 80 MG D-PANTOTHENIC ACID : 5 MG BIOTIN : 20 MCG FOLIC ACID : .14 MG PYRIDOXINE HYDROCHLORIDE : 1 MG VITAMIN E : 7 UNIT NICOTINAMIDE : 17 MG VITAMIN D : 400 UNIT |
| Manufacturer | AVENTIS PHARMA INC |
| Strength | 1.2 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XC VITAMINS |
| AHFS class | 88:28.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 29-Jul-2002 |
| Original market date | 1988-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B05XC VITAMINS. 2 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MULTI 1000 | 1.2 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00586315 |
| MULTI 12 INJECTION | 0.72 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02100606 |
| M.V.I. 12 | 660 UNIT | LIQUID | AVENTIS PHARMA INC | CANCELLED POST MARKET | DIN 01927841 |
| MEGA-C-SODIUM INJ 250MG/ML | 250 MG | SOLUTION | KRIPPS PHARMACY LTD. | DORMANT | DIN 00525189 |
| MULTI-11 | 8 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02244696 |
| MULTI-12 PEDIATRIC | 1 MCG | LIQUID | SABEX INC | CANCELLED POST MARKET | DIN 02236829 |
| MULTI-VITAMINS FOR INFUSION LIQ | 200 UNIT / 10 ML | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 01904191 |
| MVC 9 PLUS 3 INJ | 15 MG / 5 ML | LIQUID | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | CANCELLED POST MARKET | DIN 01945637 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.